Cryoglobulinemic Vasculitis

• CLINICAL_TRIALS trial_result · 2026-04-06
  Clinical Trial Update: Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients [Phase 1, Phase 2]

  Phase 1/2 trial evaluating the effectiveness and immune response of IL-2 therapy in patients with hepatitis C virus–associated cryoglobuline…

• CLINICAL_TRIALS research · 2026-01-22
  Clinical Trial Update: Clinical Transcriptomics in Systemic Vasculitis (CUTIS)

  A clinical trial update for the CUTIS study, which is recruiting to study transcriptomics in systemic vasculitis conditions.

• CLINICAL_TRIALS trial_result · 2025-12-05
  Clinical Trial Update: A Multicenter Phase 2 Single-arm Proof-of-concept Trial Assessing the Efficacy and Safety of Obinutuzumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Refractory or Intolerant to Rituximab [Phase 2]

  A multicenter Phase 2, single-arm proof-of-concept trial is evaluating obinutuzumab for non-infectious active cryoglobulinemic vasculitis in…

• CLINICAL_TRIALS trial_result · 2025-06-17
  Clinical Trial Update: Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis [Phase 2]

  This update reports results from a Phase 2 trial of a biologic therapy for refractory primary non-ANCA associated vasculitis; the study was …

• CLINICAL_TRIALS research · 2024-06-26
  Clinical Trial Update: Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis) [Phase 2]

  Phase 2 clinical trial TRIBECA is evaluating belimumab versus placebo for non-infectious cryoglobulinemic vasculitis, assessing efficacy and…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2021-11-09
  Clinical Trial Update: Isatuximab in Type I Cryoglobulinemia [Phase 2]

  Phase 2 trial update for isatuximab in cryoglobulinemic vasculitis associated with monoclonal gammopathies isatuximab is being studied; curr…

• CLINICAL_TRIALS research · 2016-09-29
  Clinical Trial Update: Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis

  This clinical trial update discusses the use of direct-acting antivirals to treat hepatitis C virus–associated cryoglobulinemic vasculitis; …

• CLINICAL_TRIALS trial_result · 2012-04-03
  Clinical Trial Update: Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis [Phase 2]

  This update summarizes a Phase 2 trial evaluating rituximab for hepatitis C–associated cryoglobulinemic vasculitis. The study has completed …